Carlsbad, CA 1/16/12—Life Technologies has agreed with DaAn Gene to form Life Technologies DaAn Diagnostics, a joint venture diagnostic business in China. DaAn Gene is a Chinese molecular in vitro diagnostic solutions provider. The joint venture will develop and commercialize molecular diagnostic assays using Life Technologies’ 3500 Dx capillary electrophoresis system and Big Dye Cycle […]
San Diego, CA 1/24/12; Basel, Germany 1/25/12; San Diego, CA 1/26/12; Basel, Germany 1/27/12; San Diego 1/27/12; Basel, Germany 1/31/12; San Diego, CA 1/31/12—Roche has launched a hostile takeover bid for Illumina, following what Roche stated were multiple efforts to negotiate directly with Illumina. Roche has commenced a tender offer for shares of Illumina for […]
Last month, the EPA finalized mercury and air toxic standards for coal- and oil-fired electric utility steam-generating units (EGUs) larger than 25 MW (see IBO 12/31/11). The so-called Utility MACT (maximum achievable control technology) establishes emissions standards for air pollutants, including mercury, arsenic, chromium, nickel and acid gases. One type of instrument for which demand […]
Seeking to solidify its position in the personalized health care market and add to its research instrument business, on January 25, Roche announced a $5.7 billion unsolicited proposal to acquire Illumina (see page 2). The announcement further bolstered expectations surrounding the use of post-Sanger sequencing, especially next-generation sequencing, in clinical and in vitro diagnostic (IVD) […]
The molecular spectroscopy market is not completely immune from a slow growing economy. Accordingly, the market’s growth should drop from more than 7% in 2011 to less than 5% in 2012. All technology segments of the molecular spectroscopy market will see a decline in their growth, although some more than others. However, every technology segment […]
Spectroscopy is a method for using a signal, generally based on a portion of the electromagnetic spectrum, to identify samples. In the case of atomic spectroscopy, the information from the instrument typically provides the elemental composition of the sample. Depending on the particular technique, atomic spectroscopy instruments can measure elemental abundance in the percent range […]
The laboratory automation market consists of four technology segments: liquid handling, microplate readers, robotics and management informatics. Collectively, these technology categories account for approximately 7% of the analytical and life science instrumentation market. The lab automation market is a fragmented market, with the sales of the top five companies accounting for about 40% of the […]
Despite a variety of negative macroeconomic factors that are expected to continue well into 2012, demand for mass spectrometry (MS) is still expected to show high single-digit growth this year, which is only modestly lower growth than in 2011. The large installed base combined with continued improvements in performance are the major factors helping to […]
The life science instrumentation (LSI) market encompasses a broad spectrum of technologies grouped into a dozen categories. LSI technologies range from mature, multibillion dollar markets to high-growth, burgeoning technology segments. Overall, the LSI market is the largest technology sector in the analytical instrument market, accounting for about a quarter of total sales. The LSI market […]
Continuing its momentum from 2010, the separations market experienced another year of solid growth. The separations market, which accounts for 17% of the total analytical and life sciences instrumentation industry, increased 8.9% to $7.3 billion in 2011. Like 2010, sales in 2011 were driven by strong demand for initial systems, which posted double-digit sales growth. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
